Basic fibroblast growth factor supports in vitro chondrogenesis of bone marrow-derived mesenchymal stem cells from patients with osteoarthritis

Hiroshi Akaogi, Takayuki Akimoto, Shigeru Miyaki, Takashi Ushida, Naoyuki Ochiai, Tetsuya Tateishi, Junzo Tanaka

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Bone marrow-derived mesenchymal stem cells (BMDMSCs) possess pluripotent differentiation potential including differentiation into osteoblasts, chondrocytes, adipocytes, and muscle cells. Using tissue engineering technology, the treatment of osteochondral lesions has been attempted with chondrocytes differentiated from mesenchymal stem cells in vitro. However, the capability of these stem cells for chondrogenic differentiation becomes gradually decreased with the passage of cell culture. Furthermore, previous studies showed that the cells from patients with osteoarthritis (OA) seemed to have reduced chondrogenic differentiation potential. It was reported that basic fibroblast growth factor (b-FGF) retained the multilinage differentiation potential of mesenchymal cells during expansion at the monolayer culture. In this study, we determined whether the BMDMSCs from patients with osteoarthritis could maintain their capability to differentiate into chondrocytes in the presence or absence of b-FGF in culture medium. We demonstrated that the chondrogenic differentiation capability of the BMDMSCs was improved by the addition of b-FGF. We concluded that bone marrow-derived stem cells from patients with osteoarthritis might be an acceptable cell source for cartilage tissue engineering.

Original languageEnglish
Pages (from-to)403-406
Number of pages4
JournalMaterials Science and Engineering C
Volume24
Issue number3
DOIs
Publication statusPublished - 2004 Apr 1
Externally publishedYes

Fingerprint

bone marrow
stem cells
fibroblasts
Fibroblast Growth Factor 2
Fibroblasts
Stem cells
Bone
cells
tissue engineering
Tissue engineering
Cell culture
muscle cells
osteoblasts
culture media
cartilage
Engineering technology
Osteoblasts
Cartilage
lesions
Culture Media

Keywords

  • Basic fibroblast growth factor
  • Chondrogenesis
  • Osteoarthritis

ASJC Scopus subject areas

  • Biomaterials

Cite this

Basic fibroblast growth factor supports in vitro chondrogenesis of bone marrow-derived mesenchymal stem cells from patients with osteoarthritis. / Akaogi, Hiroshi; Akimoto, Takayuki; Miyaki, Shigeru; Ushida, Takashi; Ochiai, Naoyuki; Tateishi, Tetsuya; Tanaka, Junzo.

In: Materials Science and Engineering C, Vol. 24, No. 3, 01.04.2004, p. 403-406.

Research output: Contribution to journalArticle

Akaogi, Hiroshi ; Akimoto, Takayuki ; Miyaki, Shigeru ; Ushida, Takashi ; Ochiai, Naoyuki ; Tateishi, Tetsuya ; Tanaka, Junzo. / Basic fibroblast growth factor supports in vitro chondrogenesis of bone marrow-derived mesenchymal stem cells from patients with osteoarthritis. In: Materials Science and Engineering C. 2004 ; Vol. 24, No. 3. pp. 403-406.
@article{5ef75c12ee6a40d78c6396ae21d96cd1,
title = "Basic fibroblast growth factor supports in vitro chondrogenesis of bone marrow-derived mesenchymal stem cells from patients with osteoarthritis",
abstract = "Bone marrow-derived mesenchymal stem cells (BMDMSCs) possess pluripotent differentiation potential including differentiation into osteoblasts, chondrocytes, adipocytes, and muscle cells. Using tissue engineering technology, the treatment of osteochondral lesions has been attempted with chondrocytes differentiated from mesenchymal stem cells in vitro. However, the capability of these stem cells for chondrogenic differentiation becomes gradually decreased with the passage of cell culture. Furthermore, previous studies showed that the cells from patients with osteoarthritis (OA) seemed to have reduced chondrogenic differentiation potential. It was reported that basic fibroblast growth factor (b-FGF) retained the multilinage differentiation potential of mesenchymal cells during expansion at the monolayer culture. In this study, we determined whether the BMDMSCs from patients with osteoarthritis could maintain their capability to differentiate into chondrocytes in the presence or absence of b-FGF in culture medium. We demonstrated that the chondrogenic differentiation capability of the BMDMSCs was improved by the addition of b-FGF. We concluded that bone marrow-derived stem cells from patients with osteoarthritis might be an acceptable cell source for cartilage tissue engineering.",
keywords = "Basic fibroblast growth factor, Chondrogenesis, Osteoarthritis",
author = "Hiroshi Akaogi and Takayuki Akimoto and Shigeru Miyaki and Takashi Ushida and Naoyuki Ochiai and Tetsuya Tateishi and Junzo Tanaka",
year = "2004",
month = "4",
day = "1",
doi = "10.1016/j.msec.2003.12.017",
language = "English",
volume = "24",
pages = "403--406",
journal = "Materials Science and Engineering C",
issn = "0928-4931",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Basic fibroblast growth factor supports in vitro chondrogenesis of bone marrow-derived mesenchymal stem cells from patients with osteoarthritis

AU - Akaogi, Hiroshi

AU - Akimoto, Takayuki

AU - Miyaki, Shigeru

AU - Ushida, Takashi

AU - Ochiai, Naoyuki

AU - Tateishi, Tetsuya

AU - Tanaka, Junzo

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Bone marrow-derived mesenchymal stem cells (BMDMSCs) possess pluripotent differentiation potential including differentiation into osteoblasts, chondrocytes, adipocytes, and muscle cells. Using tissue engineering technology, the treatment of osteochondral lesions has been attempted with chondrocytes differentiated from mesenchymal stem cells in vitro. However, the capability of these stem cells for chondrogenic differentiation becomes gradually decreased with the passage of cell culture. Furthermore, previous studies showed that the cells from patients with osteoarthritis (OA) seemed to have reduced chondrogenic differentiation potential. It was reported that basic fibroblast growth factor (b-FGF) retained the multilinage differentiation potential of mesenchymal cells during expansion at the monolayer culture. In this study, we determined whether the BMDMSCs from patients with osteoarthritis could maintain their capability to differentiate into chondrocytes in the presence or absence of b-FGF in culture medium. We demonstrated that the chondrogenic differentiation capability of the BMDMSCs was improved by the addition of b-FGF. We concluded that bone marrow-derived stem cells from patients with osteoarthritis might be an acceptable cell source for cartilage tissue engineering.

AB - Bone marrow-derived mesenchymal stem cells (BMDMSCs) possess pluripotent differentiation potential including differentiation into osteoblasts, chondrocytes, adipocytes, and muscle cells. Using tissue engineering technology, the treatment of osteochondral lesions has been attempted with chondrocytes differentiated from mesenchymal stem cells in vitro. However, the capability of these stem cells for chondrogenic differentiation becomes gradually decreased with the passage of cell culture. Furthermore, previous studies showed that the cells from patients with osteoarthritis (OA) seemed to have reduced chondrogenic differentiation potential. It was reported that basic fibroblast growth factor (b-FGF) retained the multilinage differentiation potential of mesenchymal cells during expansion at the monolayer culture. In this study, we determined whether the BMDMSCs from patients with osteoarthritis could maintain their capability to differentiate into chondrocytes in the presence or absence of b-FGF in culture medium. We demonstrated that the chondrogenic differentiation capability of the BMDMSCs was improved by the addition of b-FGF. We concluded that bone marrow-derived stem cells from patients with osteoarthritis might be an acceptable cell source for cartilage tissue engineering.

KW - Basic fibroblast growth factor

KW - Chondrogenesis

KW - Osteoarthritis

UR - http://www.scopus.com/inward/record.url?scp=1842780119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842780119&partnerID=8YFLogxK

U2 - 10.1016/j.msec.2003.12.017

DO - 10.1016/j.msec.2003.12.017

M3 - Article

AN - SCOPUS:1842780119

VL - 24

SP - 403

EP - 406

JO - Materials Science and Engineering C

JF - Materials Science and Engineering C

SN - 0928-4931

IS - 3

ER -